Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE).
Saved in:
| Title: | Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE). |
|---|---|
| Authors: | Tan X; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA. mxtz@novonordisk.com., Divino V; IQVIA, Falls Church, VA, USA., Amamoo J; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA., Xie L; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA., Coyle KB; IQVIA, Falls Church, VA, USA., Gamble CL; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA., Guevarra M; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA., Paprocki Y; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA., King AA; Baptist Health System, San Antonio, TX, USA. |
| Source: | Clinical drug investigation [Clin Drug Investig] 2024 Apr; Vol. 44 (4), pp. 271-284. Date of Electronic Publication: 2024 Mar 20. |
| Publication Type: | Observational Study; Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38507188 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tan+X%22">Tan X</searchLink>; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA. mxtz@novonordisk.com.<br /><searchLink fieldCode="AU" term="%22Divino+V%22">Divino V</searchLink>; IQVIA, Falls Church, VA, USA.<br /><searchLink fieldCode="AU" term="%22Amamoo+J%22">Amamoo J</searchLink>; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA.<br /><searchLink fieldCode="AU" term="%22Xie+L%22">Xie L</searchLink>; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA.<br /><searchLink fieldCode="AU" term="%22Coyle+KB%22">Coyle KB</searchLink>; IQVIA, Falls Church, VA, USA.<br /><searchLink fieldCode="AU" term="%22Gamble+CL%22">Gamble CL</searchLink>; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA.<br /><searchLink fieldCode="AU" term="%22Guevarra+M%22">Guevarra M</searchLink>; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA.<br /><searchLink fieldCode="AU" term="%22Paprocki+Y%22">Paprocki Y</searchLink>; Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ, 08536, USA.<br /><searchLink fieldCode="AU" term="%22King+AA%22">King AA</searchLink>; Baptist Health System, San Antonio, TX, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229504817%22">Clinical drug investigation</searchLink> [Clin Drug Investig] 2024 Apr; Vol. 44 (4), pp. 271-284. <i>Date of Electronic Publication: </i>2024 Mar 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Observational Study; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9504817 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1918 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211732563%22">11732563 </searchLink><i>NLM ISO Abbreviation: </i>Clin Drug Investig <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38507188 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40261-024-01354-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 271 Titles: – TitleFull: Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tan X – PersonEntity: Name: NameFull: Divino V – PersonEntity: Name: NameFull: Amamoo J – PersonEntity: Name: NameFull: Xie L – PersonEntity: Name: NameFull: Coyle KB – PersonEntity: Name: NameFull: Gamble CL – PersonEntity: Name: NameFull: Guevarra M – PersonEntity: Name: NameFull: Paprocki Y – PersonEntity: Name: NameFull: King AA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2024 Apr Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1179-1918 Numbering: – Type: volume Value: 44 – Type: issue Value: 4 Titles: – TitleFull: Clinical drug investigation Type: main |
| ResultId | 1 |
